CEACAM5 and familial pancreatic carcinoma: The current study aimed to estimate the level of CEMIP, CA19-9 and CEA in pancreatic cancer patients and evaluate the clinical utility of serum CEMIP, CA19-9 and CEA in diagnosis of pancreatic cancer patients.